Skip to content

X Linked Lymphoproliferative Disease Due To Xiap Deficiency C1845076

Published: July 22, 2026Updated: August 26, 2026

An immune disorder from XIAP gene mutations causing abnormal immune responses. Mainly affects males. Treatment involves immunosuppressive therapy and supportive care.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 26, 2026Editorial policy

Key facts at a glance

ICD-10
D89.9
ICD-11
3A00.0
Body system
immunologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Hemophagocytic lymphohistiocytosis (HLH)

Generalized symptoms

(immunologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Recurrent fevers

(immunologic)

Inflammatory bowel disease (IBD)

(immunologic)

Uveitis

(immunologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Hematopoietic Stem Cell Transplantation

HSCT is the primary curative approach for XIAP deficiency, replacing defective immune cells with healthy donor cells. This procedure addresses the underlying immune dysfunction and can resolve life-threatening complications.

procedure
2

Medication management with follow-up care

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Immunoglobulin Replacement Therapy

Regular intravenous or subcutaneous immunoglobulin infusions provide passive immunity to compensate for antibody deficiencies. This reduces susceptibility to bacterial infections and may help control inflammatory manifestations.

medication

Additional treatment options

Prophylactic Antimicrobial Therapy

Antibiotic prophylaxis, often with trimethoprim-sulfamethoxazole, protects against opportunistic bacterial infections. Antiviral prophylaxis may also be considered given the viral susceptibility in these patients.

medication

Regular Immunological and Clinical Monitoring

Comprehensive monitoring includes periodic immune function assessments, liver function tests, and screening for inflammatory complications. Early detection of complications allows for timely intervention.

monitoring

Infection Prevention and Avoidance Strategies

Implementing rigorous hand hygiene, avoiding contact with ill individuals, and maintaining up-to-date vaccinations (excluding live vaccines) reduces infection risk. Education for caregivers and family members is essential.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is X Linked Lymphoproliferative Disease Due To Xiap Deficiency C1845076?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Pachlopnik Schmid J, et al. Management of XIAP deficiency: International consensus recommendations. J Clin Immunol. 2022.

guideline2022
2

Worth AJ, et al. X-linked inhibitor of apoptosis deficiency: Pathogenesis and clinical manifestations. Immunol Allergy Clin North Am. 2020.

review2020
3

Lev A, et al. Treatment outcomes in XIAP-deficient patients: A multicenter cohort study. Blood. 2021.

clinical_trial2021
4

Zhang K, et al. Hematopoietic stem cell transplantation for XIAP deficiency. Bone Marrow Transplant. 2023.

review2023

Medication Comparisons

Compare medications used to treat X Linked Lymphoproliferative Disease Due To Xiap Deficiency C1845076. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 26, 2026. · Read our editorial policy